Search Results - Delea, Thomas E

Network Meta-analysis of Progression-Free Survival and Overall Survival in First-Line Treatment of BRAF Mutation-Positive Metastatic Melanoma by Amdahl, Jordan, Chen, Lei, Delea, Thomas E.

Get full text Get full text Get full text

Retrospective Study of the Prevalence, Predictors, and Consequences of Nonadherence With Lapatinib in Women With Metastatic Breast Cancer Who Were Previously Treated With Trastuzum... by Delea, Thomas E., Kartashov, Alex, Sharma, Puza P.

Get full text Get full text Get full text

Utilization of intravenous bisphosphonates in patients with bone metastases secondary to breast, lung, or prostate cancer by Hagiwara, May, Delea, Thomas E., Cong, Ze, Chung, Karen

Get full text Get full text Get full text

Preferences of Canadian Patients and Physicians for Treatment of HR+/HER2− Advanced Breast Cancer by Stellato, Daniel, Thabane, Marroon, Eichten, Caitlin, Delea, Thomas E.

Get full text Get full text Get full text

Cost-effectiveness of pazopanib versus sunitinib for metastatic renal cell carcinoma in the United Kingdom by Amdahl, Jordan, Diaz, Jose, Sharma, Arati, Park, Jinhee, Chandiwana, David, Delea, Thomas E.

Get full text Get full text Get full text

Cost Effectiveness of Labetalol and Propranolol in the Treatment of Hypertension Among Blacks by Oster, Gerry, Huse, Daniel M., Delea, Thomas E., Savage, Daniel D., Colditz, Graham A.

Get full text Get full text

Cost-Effectiveness of Lapatinib plus Letrozole in Post-Menopausal Women with Hormone Receptor-and HER2-Positive Metastatic Breast Cancer by Delea, Thomas E., Hawkes, Carol, Amonkar, Mayur M., Lykopoulos, Konstantinos, Johnston, Stephen R. D.

Get full text Get full text Get full text

Estimating outcomes and cost effectiveness using a single-arm clinical trial: ofatumumab for double-refractory chronic lymphocytic leukemia by Hatswell, Anthony J., Thompson, Gwilym J., Maroudas, Penny A., Sofrygin, Oleg, Delea, Thomas E.

Get full text Get full text Get full text

Budget Impact Analysis of PCSK9 Inhibitors for the Management of Adult Patients with Heterozygous Familial Hypercholesterolemia or Clinical Atherosclerotic Cardiovascular Disease by Mallya, Usha G., Boklage, Susan H., Koren, Andrew, Delea, Thomas E., Mullins, C. Daniel

Get full text Get full text Get full text

Cost Effectiveness of Blinatumomab Versus Inotuzumab Ozogamicin in Adult Patients with Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia in the United States by Delea, Thomas E., Zhang, Xinke, Amdahl, Jordan, Boyko, Diana, Dirnberger, Franziska, Campioni, Marco, Cong, Ze

Get full text Get full text Get full text

Cost-Effectiveness of Pazopanib in Advanced Soft Tissue Sarcoma in the United Kingdom by Amdahl, Jordan, Manson, Stephanie C., Isbell, Robert, Chit, Ayman, Diaz, Jose, Lewis, Lily, Delea, Thomas E.

Get full text Get full text Get full text

Cost-effectiveness of alternate strategies for childhood immunization against meningococcal disease with monovalent and quadrivalent conjugate vaccines in Canada by Delea, Thomas E., Weycker, Derek, Atwood, Mark, Neame, Dion, Alvarez, Fabián P., Forget, Evelyn, Langley, Joanne M., Chit, Ayman

Get full text Get full text Get full text

Cost-Effectiveness of Aliskiren in Type 2 Diabetes, Hypertension, and Albuminuria by Delea, Thomas E., Sofrygin, Oleg, Palmer, James L., Lau, Helen, Munk, Veronica C., Sung, Jennifer, Charney, Alan, Parving, Hans-Henrik, Sullivan, Sean D.

Get full text Get full text Get full text

Matching-Adjusted Indirect Comparison of Ribociclib Plus Fulvestrant versus Palbociclib Plus Letrozole as First-Line Treatment of HR+/HER2− Advanced Breast Cancer by Fasching, Peter A, Delea, Thomas E, Lu, Yen-Shen, De Boer, Richard, Hurvitz, Sara A, Moynahan, Aaron, Chandiwana, David, Lanoue, Brad, Hu, Huilin, Thuerigen, Astrid, O’Shaughnessy, Joyce

Get full text Get full text Get full text